0001493152-21-015592.txt : 20210629
0001493152-21-015592.hdr.sgml : 20210629
20210629172059
ACCESSION NUMBER: 0001493152-21-015592
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210629
DATE AS OF CHANGE: 20210629
EFFECTIVENESS DATE: 20210629
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESQ PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001805243
IRS NUMBER: 833795334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-404660
FILM NUMBER: 211059211
BUSINESS ADDRESS:
STREET 1: 59-780 KAPUHI PLACE
CITY: HALEIWA
STATE: HI
ZIP: 96712
BUSINESS PHONE: 9493713993
MAIL ADDRESS:
STREET 1: 59-780 KAPUHI PLACE
CITY: HALEIWA
STATE: HI
ZIP: 96712
D
1
primary_doc.xml
X0708
D
LIVE
0001805243
RESQ PHARMACEUTICALS INC.
3535 EXECUTIVE TERMINAL DRIVE
SUITE 110
HENDERSON
NV
NEVADA
89052
(701) 541-9222
DELAWARE
None
None
Corporation
true
2019
BEN
ESQUE
3535 EXECUTIVE TERMINAL DRIVE
SUITE 110
HENDERSON
NV
NEVADA
89052
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-06-14
false
true
false
0
None
None
None
None
NONE
NONE
NONE
XX
Unknown
None
AZ
ARIZONA
CA
CALIFORNIA
CO
COLORADO
HI
HAWAII
IL
ILLINOIS
MI
MICHIGAN
NE
NEBRASKA
NV
NEVADA
SC
SOUTH CAROLINA
TN
TENNESSEE
TX
TEXAS
WA
WASHINGTON
false
10000000
8804985
1195015
false
52
0
0
9950000
true
false
RESQ PHARMACEUTICALS INC.
/s/ Ben Esque
Ben Esque
Chief Executive Officer
2021-06-29